(Total Views: 101)
Posted On: 02/03/2017 9:48:30 AM
Post# of 72446
Looking at the Kevetrin study that will start next week I am delighted by two things.
First, I remember that they were initially doing a combo trial with another medication but it doesn't look like it anymore so this will be Kevetrin against Platinum Resistant cancer which is to me a big sign of confidence by Dr. Mennon.
Second, the outcomes will be measured within days and in some cases just 3 weeks. This means unlike the first Kevetrin study, CTIX and the investigators will know in March how we're doing!
First, I remember that they were initially doing a combo trial with another medication but it doesn't look like it anymore so this will be Kevetrin against Platinum Resistant cancer which is to me a big sign of confidence by Dr. Mennon.
Second, the outcomes will be measured within days and in some cases just 3 weeks. This means unlike the first Kevetrin study, CTIX and the investigators will know in March how we're doing!
(5)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
